September 17, 2018

Vesalio NeVa Neurothrombectomy Platform Launched at ESMINT Congress

September 18, 2018—Vesalio announced that it initiated the full commercial European launch of its NeVa neurothrombectomy platform at the 10th annual congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT), which was held September 6–8 in Nice, France.

With the conclusion of the controlled launch in the European Union, Vesalio will now expand the number of NeVa centers in Europe while commencing the establishment of its distributor network in the Asia-Pacific, Middle East & Africa, and Americas regions.

According to the company, Vesalio’s flow model was utilized to simulate the navigation and deployment of NeVa’s Drop Zone and Smart Marker technology. The NeVa platform was designed to improve first-pass success with all clot types, including hard and organized clots.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

September 17, 2018

Vesalio NeVa Neurothrombectomy Platform Launched at ESMINT Congress

Current Issue

Keep In Touch